As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage. By providing infrastructure, services, educational programs and networks in global hotspots, JLABS is the best place to start a company working in healthcare, with a specific emphasis on Johnson & Johnson’s sectors: consumer, medical device and pharmaceuticals.

Previously, Melinda was Founder & CEO of Prescience International, an award-winning firm dedicated to accelerating research to the patient. Melinda founded Prescience after a medical emergency that left her questioning the efficiency and efficacy of the healthcare system. She set out to create a better model, which now forms the basis for JLABS’ operational infrastructure. Prior to Prescience, Melinda held posts across a variety of functional areas with a global corporation, Nortel Networks.

She holds a Bachelor of Commerce from the University of Saskatchewan in Canada and a MBA from INSEAD in France. Melinda is an active board member and Treasurer of the California Life Sciences Association (CLSA).